Miarka J, Jonderko G, Straszecka J, Lachowicz B
IV Katedry i Kliniki Chorób Wewnetrznych Slaskiej Akademii Medycznej Kierownik.
Przegl Lek. 1990;47(4):385-8.
Acetylation phenotype was determined in 184 diabetics: 102 patients with Type I (insulin-dependent) and 82 patients with Type II (non-insulin-dependent) diabetes mellitus, who underwent complex investigations to assess the development of sensorimotor and autonomic neuropathy. The control group consisted of 121 healthy subjects of the same age distribution. The results obtained imply that the slow acetylation phenotype may be considered as a significant risk factor of diabetic neuropathy.
对184名糖尿病患者进行了乙酰化表型测定：其中102例为I型（胰岛素依赖型）糖尿病患者，82例为II型（非胰岛素依赖型）糖尿病患者，这些患者均接受了综合检查以评估感觉运动和自主神经病变的发展情况。对照组由121名年龄分布相同的健康受试者组成。所得结果表明，慢乙酰化表型可能被视为糖尿病神经病变的一个重要危险因素。
